Skip to content

Kaletra effective and well tolerated in PI-experienced patients

Failure of three main classes of antiretrovirals present in 12% of EuroSIDA cohort

Roche will not go ahead with nelfinavir 625mg formulation in Europe: cites production problems

Higher than expected incidence of HIV found in injecting drug users in London

Keeping track of patients and drugs in rural Haiti: electronic system is practical

HIV protease inhibitors may also check malaria

HIV-positive former IDUs have poorer immune response to HAART

Core group of patients with drug resistant HIV engaging in risky sex identified by US study

Ranbaxy announces withdrawal of all generic ARVs from WHO list